Need professional-grade analysis? Visit stockanalysis.com
$185.25M
93.07
833
6.18%
Oriola (ORIOLA) trades on Nasdaq Helsinki in EUR. The company is classified in the Healthcare sector under the Pharmaceutical Retailers industry. The stock currently trades at EUR0.98, down 3.35% from the previous close.
Over the past year, ORIOLA has traded between a low of EUR0.97 and a high of EUR1.25. The stock has lost 13.1% over this period. It is currently 21.9% below its 52-week high.
Oriola has a market capitalization of $185.25M, with a price-to-earnings ratio of 93.07 and a dividend yield of 6.18%.
Oriola Oyj engages in the wholesale of pharmaceuticals and health products in Sweden, Finland, and internationally. The company distributes vitamins, food and food supplements, sports nutrients, wound care, beauty, and makeup related products; vaccines; and over-the-counter products. In addition, it provides pharmaceutical logistics; special licensed medicine importing, dose dispensing, and research pharmacy services; and commercial data, clinical trial, regulatory affairs and quality, medical and scientific affairs, market access and tenders, real world evidence, sales support, medical translation, pharmacovigilance and medical information, and patient support services. Further, the company provides advisory services. It serves pharmaceutical companies, pharmacies, veterinarians, hospitals, healthcare providers, special stores, retailers, and e-commerce companies. The company was founded in 1907 and is headquartered in Espoo, Finland.